OPTN - OptiNose granted FDA nod to expand labeling for sinusitis therapy March, 16 2024 08:37 AM OptiNose Inc. 2024-03-16 08:37:06 ET More on OptiNose OptiNose, Inc. 2023 Q4 - Results - Earnings Call Presentation OptiNose, Inc. (OPTN) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on OptiNose Historical earnings data for OptiNose Financial information for OptiNose For further details see: OptiNose granted FDA nod to expand labeling for sinusitis therapy